Monday 27 December 2010

Dacocilin




Dacocilin may be available in the countries listed below.


Ingredient matches for Dacocilin



Dicloxacillin

Dicloxacillin sodium salt (a derivative of Dicloxacillin) is reported as an ingredient of Dacocilin in the following countries:


  • Taiwan

International Drug Name Search

Sunday 26 December 2010

Citafan




Citafan may be available in the countries listed below.


Ingredient matches for Citafan



Cytarabine

Cytarabine is reported as an ingredient of Citafan in the following countries:


  • Peru

International Drug Name Search

Saturday 25 December 2010

Vinblastina Filaxis




Vinblastina Filaxis may be available in the countries listed below.


Ingredient matches for Vinblastina Filaxis



Vinblastine

Vinblastine sulfate (a derivative of Vinblastine) is reported as an ingredient of Vinblastina Filaxis in the following countries:


  • Argentina

International Drug Name Search

Thursday 23 December 2010

Comtrex G Frambuesa




Comtrex G Frambuesa may be available in the countries listed below.


Ingredient matches for Comtrex G Frambuesa



Benzocaine

Benzocaine is reported as an ingredient of Comtrex G Frambuesa in the following countries:


  • Peru

International Drug Name Search

Wednesday 22 December 2010

Zaart




Zaart may be available in the countries listed below.


Ingredient matches for Zaart



Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Zaart in the following countries:


  • Sri Lanka

International Drug Name Search

Bedozane




Bedozane may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Bedozane



Flunixin

Flunixin meglumine (a derivative of Flunixin) is reported as an ingredient of Bedozane in the following countries:


  • Belgium

  • Netherlands

International Drug Name Search

Tuesday 21 December 2010

Ticlopidina Winthrop




Ticlopidina Winthrop may be available in the countries listed below.


Ingredient matches for Ticlopidina Winthrop



Ticlopidine

Ticlopidine hydrochloride (a derivative of Ticlopidine) is reported as an ingredient of Ticlopidina Winthrop in the following countries:


  • Portugal

International Drug Name Search

Thursday 16 December 2010

Donaren




Donaren may be available in the countries listed below.


Ingredient matches for Donaren



Trazodone

Trazodone hydrochloride (a derivative of Trazodone) is reported as an ingredient of Donaren in the following countries:


  • Brazil

International Drug Name Search

Sunday 12 December 2010

Potassio cloruro B Braun




Potassio cloruro B Braun may be available in the countries listed below.


Ingredient matches for Potassio cloruro B Braun



Potassium Chloride

Potassium Chloride is reported as an ingredient of Potassio cloruro B Braun in the following countries:


  • Italy

International Drug Name Search

Saturday 11 December 2010

Lanreotide




In the US, Lanreotide (lanreotide systemic) is a member of the drug class somatostatin and somatostatin analogs and is used to treat Acromegaly.

US matches:

  • Lanreotide

  • Lanreotide Subcutaneous

  • Lanreotide Acetate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

H01CB03

CAS registry number (Chemical Abstracts Service)

0108736-35-2

Chemical Formula

C54-H69-N11-O10-S2

Molecular Weight

1096

Therapeutic Categories

Antineoplastic agent

Growth hormone release inhibiting hormone analogue (analogue of somatostatin)

Chemical Names

3-(2-Naphthyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamid, cycl.(2-7)-disulfid (IUPAC)

3-(2-Naphthyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide, cyclic (2->7)-disulfide (WHO)

L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2->7)-disulfide

Foreign Names

  • Lanreotidum (Latin)
  • Lanreotid (German)
  • Lanréotide (French)
  • Lanreotida (Spanish)

Generic Names

  • Lanreotide (OS: BAN)
  • Lanréotide (OS: DCF)
  • BIM 23014 (IS)
  • BN 52030 (IS)
  • Lanreotide Acetate (OS: USAN)
  • BIM 23014C (IS: Ipsen)

Brand Names

  • Ipstyl Lyfjaver
    Lyfjaver, Iceland


  • Ipstyl
    Ipsen, Italy


  • Somatulina LP
    Ipsen, Portugal


  • Somatuline
    Gen, Turkey; Ipsen, Slovakia


  • Somatuline PR
    Beaufour Ipsen, Taiwan


  • Ipstyl
    Ipsen, Denmark; Ipsen, Iceland; Ipsen, Italy; Ipsen, Norway


  • Somatulina Autogel
    Ipsen, Spain; Ipsen, Portugal


  • Somatulina
    Ipsen, Spain; Ipsen, Portugal


  • Somatuline retard
    Ipsen, Austria


  • Somatuline
    Beaufour Ipsen, Hungary; Beaufour Ipsen, Poland; Beaufour Ipsen, Romania; Delphi, Netherlands; Dr. Fisher, Netherlands; EU-Pharma, Netherlands; Ipsen, Australia; Ipsen, Belgium; Ipsen, Czech Republic; Ipsen, Estonia; Ipsen, Finland; Ipsen, France; Ipsen, United Kingdom; Ipsen, Greece; Ipsen, Ireland; Ipsen, Israel; Ipsen, Latvia; Ipsen, Netherlands; Ipsen, Serbia; Ipsen, Russian Federation; Ipsen, Slovakia; Ipsen, United States; Medcor, Netherlands; Stephar, Netherlands; Synthesis, Colombia


  • Somatuline Autogel
    Beaufour Ipsen, Romania; Globopharm, Switzerland; Ipsen, Austria; Ipsen, Australia; Ipsen, Germany; Ipsen, Ireland; Ipsen, Israel; Ipsen, Lithuania; Ipsen, Luxembourg; Ipsen, Serbia; Ipsen, Sweden; PharmaSwiss, Slovenia; Sidus, Argentina


  • Somatuline PR
    Ipsen, Czech Republic; Ipsen, Finland; Ipsen, Hong Kong; Ipsen, Lithuania; Ipsen, Luxembourg; Ipsen, Netherlands; Ipsen, Poland


  • Somatuline
    PRIpsen, Sweden


  • Somatuline PR
    PharmaSwiss, Slovenia

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday 10 December 2010

Restasis


Restasis is a brand name of cyclosporine ophthalmic, approved by the FDA in the following formulation(s):


RESTASIS (cyclosporine - emulsion; ophthalmic)



  • Manufacturer: ALLERGAN

    Approval date: December 23, 2002

    Strength(s): 0.05% [RLD]

Has a generic version of Restasis been approved?


No. There is currently no therapeutically equivalent version of Restasis available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Restasis. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Nonirritating emulsions for sensitive tissue
    Patent 5,474,979
    Issued: December 12, 1995
    Inventor(s): Ding; Shulin & Tien; Walter L. & Olejnik; Orest
    Assignee(s): Allergan, Inc.
    A pharmaceutical composition is disclosed in the form of a nonirritating emulsion which includes at least one cyclosporin in admixture with a higher fatty acid glyceride and polysorbate 80. More particularly, the cyclosporin may be cyclosporin A and the higher fatty acid glyceride may be castor oil. Composition has been found to be of a high comfort level and low irritation potential suitable for delivery of medications to sensitive areas such as ocular tissues. In addition, the composition has stability for up to nine months without crystallization of cyclosporin.
    Patent expiration dates:

    • May 17, 2014
      ✓ 
      Drug product



See also...

  • Restasis Consumer Information (Drugs.com)
  • Restasis Drops Consumer Information (Wolters Kluwer)
  • Restasis Consumer Information (Cerner Multum)
  • Restasis Advanced Consumer Information (Micromedex)
  • Restasis eent AHFS DI Monographs (ASHP)
  • Cyclosporine Drops Consumer Information (Wolters Kluwer)
  • Cyclosporine ophthalmic Consumer Information (Cerner Multum)
  • Cyclosporine Ophthalmic Advanced Consumer Information (Micromedex)
  • Cyclosporine eent AHFS DI Monographs (ASHP)

Thursday 9 December 2010

Witcop




Witcop may be available in the countries listed below.


Ingredient matches for Witcop



Aluminium Hydroxide

Aluminium Hydroxide is reported as an ingredient of Witcop in the following countries:


  • Japan

Magnesium Hydroxide

Magnesium Hydroxide is reported as an ingredient of Witcop in the following countries:


  • Japan

International Drug Name Search

Tuesday 7 December 2010

Pepdine




Pepdine may be available in the countries listed below.


Ingredient matches for Pepdine



Famotidine

Famotidine is reported as an ingredient of Pepdine in the following countries:


  • Egypt

  • France

International Drug Name Search

ratio-Fentanyl




ratio-Fentanyl may be available in the countries listed below.


Ingredient matches for ratio-Fentanyl



Fentanyl

Fentanyl is reported as an ingredient of ratio-Fentanyl in the following countries:


  • Canada

International Drug Name Search

Sunday 5 December 2010

Magne-B6




Magne-B6 may be available in the countries listed below.


Ingredient matches for Magne-B6



Magnesium Lactate

Magnesium Lactate is reported as an ingredient of Magne-B6 in the following countries:


  • Poland

Pyridoxine

Pyridoxine is reported as an ingredient of Magne-B6 in the following countries:


  • Poland

International Drug Name Search

Cetirizina Idifarma




Cetirizina Idifarma may be available in the countries listed below.


Ingredient matches for Cetirizina Idifarma



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cetirizina Idifarma in the following countries:


  • Spain

International Drug Name Search

Friday 3 December 2010

Humex toux sèche dextrométhorphane




Humex toux sèche dextrométhorphane may be available in the countries listed below.


Ingredient matches for Humex toux sèche dextrométhorphane



Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Humex toux sèche dextrométhorphane in the following countries:


  • France

International Drug Name Search